{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:02:00Z","timestamp":1791615720378,"version":"4.3.4"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00210-026-05269-x","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T07:46:20Z","timestamp":1775029580000},"page":"13781-13805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dasatinib Cube-O-Needle hybrid system for effective and safe site-specific treatment for triple-negative breast cancer"],"prefix":"10.1007","volume":"399","author":[{"given":"Hardik","family":"Rana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shachi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejal","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"5269_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/J.CHPHI.2023.100247","volume":"7","author":"MST Abdul Azeeze","year":"2023","unstructured":"Abdul Azeeze MST, Kandasamy S, Palanisamy P et al (2023) Cocrystallization of Dasatinib with different acids improves the solubility and physicochemical properties: a combined experimental and theoretical studies. Chem Phys Impact 7:100247. https:\/\/doi.org\/10.1016\/J.CHPHI.2023.100247","journal-title":"Chem Phys Impact"},{"key":"5269_CR2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2147\/BCTT.S516125","volume":"7","author":"A Agelidis","year":"2025","unstructured":"Agelidis A, Ter-zakarian A, Jaloudi M (2025) Breast cancer: targets and therapy triple-negative breast cancer on the rise: breakthroughs and beyond. Breast Cancer Targets Ther Open 7:523\u2013529","journal-title":"Breast Cancer Targets Ther Open"},{"key":"5269_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/J.JCONREL.2022.04.043","volume":"347","author":"M Ali","year":"2022","unstructured":"Ali M, Namjoshi S, Benson HAE et al (2022) Dissolvable polymer microneedles for drug delivery and diagnostics. J Control Release 347:561\u2013589. https:\/\/doi.org\/10.1016\/J.JCONREL.2022.04.043","journal-title":"J Control Release"},{"key":"5269_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/PHARMACEUTICS16020200\/S1","volume":"16","author":"D Ando","year":"2024","unstructured":"Ando D, Miyatsuji M, Sakoda H et al (2024) Mechanical characterization of dissolving microneedles: factors affecting physical strength of needles. Pharmaceutics 16:200. https:\/\/doi.org\/10.3390\/PHARMACEUTICS16020200\/S1","journal-title":"Pharmaceutics"},{"key":"5269_CR5","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/MI12111321","volume":"12","author":"M Avcil","year":"2021","unstructured":"Avcil M, \u00c7elik A (2021) Microneedles in drug delivery: progress and challenges. Micromachines 12:1321. https:\/\/doi.org\/10.3390\/MI12111321","journal-title":"Micromachines"},{"key":"5269_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s40005-024-00711-9","volume":"55","author":"P Balakrishnan","year":"2025","unstructured":"Balakrishnan P, Junaid S, Ahmad S et al (2025) Novel microneedle patches for transdermal delivery of AP39, a hydrogen sulphide donor, in the treatment of scenarios mimicking neurological disorders. J Pharm Investig 55:603\u2013616","journal-title":"J Pharm Investig"},{"key":"5269_CR7","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1007\/s12668-024-01512-y","volume":"14","author":"I Batool","year":"2024","unstructured":"Batool I, Zafar N, Ahmad Z et al (2024) Nanoparticle - loaded microneedle patch for transdermal delivery of letrozole. Bionanoscience 14:2131\u20132144","journal-title":"Bionanoscience"},{"key":"5269_CR8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s10924-022-02654-4","volume":"31","author":"A Behl","year":"2023","unstructured":"Behl A, Solanki S (2023) Biodegradable PEG-PCL nanoparticles for co-delivery of MUC1 inhibitor and doxorubicin for the confinement of triple-negative breast cancer. J Polym Environ 31:999\u20131018. https:\/\/doi.org\/10.1007\/s10924-022-02654-4","journal-title":"J Polym Environ"},{"key":"5269_CR9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/J.DRUDIS.2018.12.002","volume":"24","author":"S Beg","year":"2019","unstructured":"Beg S, Rahman M, Kohli K (2019) Quality-by-design approach as a systematic tool for the development of nanopharmaceutical products. Drug Discov Today 24:717\u2013725. https:\/\/doi.org\/10.1016\/J.DRUDIS.2018.12.002","journal-title":"Drug Discov Today"},{"key":"5269_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13893-8","author":"S Bertozzi","year":"2025","unstructured":"Bertozzi S, Londero AP, Andres J et al (2025) Breast cancer care for the aging population: a focus on age \u2011 related disparities in breast cancer treatment. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-025-13893-8","journal-title":"BMC Cancer"},{"key":"5269_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.22270\/JDDT.V14I3.6464","volume":"14","author":"A Bhageerathy","year":"2024","unstructured":"Bhageerathy A, Prasanth VV (2024) Formulation and evaluation of moxifloxacin hydrochloride loaded cubosomal gel for ocular delivery. J Drug Deliv Ther 14:88\u201399. https:\/\/doi.org\/10.22270\/JDDT.V14I3.6464","journal-title":"J Drug Deliv Ther"},{"key":"5269_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.126108","volume":"684","author":"AH Bhatt","year":"2025","unstructured":"Bhatt AH, Patel HP, Patel PR et al (2025) Cubosomes in non-oral drug delivery: advancing precision therapeutics from bench to bedside. Int J Pharm 684:126108. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.126108","journal-title":"Int J Pharm"},{"key":"5269_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/J.JDDST.2024.106112","volume":"101","author":"KK Boddu","year":"2024","unstructured":"Boddu KK, Gubbiyappa KS (2024) Multi-factor optimization and interaction analysis for enhanced nanobubble formulation and performance of Dasatinib. J Drug Deliv Sci Technol 101:106112. https:\/\/doi.org\/10.1016\/J.JDDST.2024.106112","journal-title":"J Drug Deliv Sci Technol"},{"key":"5269_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ph18070959","volume":"18","author":"L Budau","year":"2025","unstructured":"Budau L (2025) Beyond the basics: exploring pharmacokinetic interactions and safety in tyrosine-kinase inhibitor oral therapy for solid tumors. Pharmaceuticals 18:959","journal-title":"Pharmaceuticals"},{"key":"5269_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e40658","volume":"10","author":"A Cammarano","year":"2024","unstructured":"Cammarano A, Dello S, Battisti M et al (2024) A systematic review of microneedles technology in drug delivery through a bibliometric and patent overview. Heliyon 10:e40658. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40658","journal-title":"Heliyon"},{"key":"5269_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21037\/tbcr-24-28","volume":"6","author":"FM Carvalho","year":"2025","unstructured":"Carvalho FM (2025) Targeting low-risk triple-negative breast cancer\u202f: a review on de- escalation strategies for a new era. Transl Breast Cancer Res 6:24\u201328. https:\/\/doi.org\/10.21037\/tbcr-24-28","journal-title":"Transl Breast Cancer Res"},{"key":"5269_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15092308","volume":"15","author":"L Casula","year":"2023","unstructured":"Casula L, Pireddu R, Cardia MC et al (2023) Nanosuspension-based dissolvable microneedle arrays to enhance diclofenac skin delivery. Pharmaceutics 15:2308","journal-title":"Pharmaceutics"},{"issue":"16","key":"5269_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/POLYM16162377","volume":"16","author":"T Chaiwarit","year":"2024","unstructured":"Chaiwarit T, Chanabodeechalermrung B, Jantrawut P et al (2024) Fabrication and characterization of dissolving microneedles containing Oryza sativa L. extract complex for enhancement of transfollicular delivery. Polymers 16(16):2377. https:\/\/doi.org\/10.3390\/POLYM16162377","journal-title":"Polymers"},{"key":"5269_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/acsptsci.4c00492","volume":"8","author":"AG Chapdelaine","year":"2025","unstructured":"Chapdelaine AG, Sun G (2025) Molecular pharmacology of dasatinib provides unique insights into the mechanistic basis of success and failure of targeted cancer therapy. ACS Pharmacol Transl Sci 8:1\u20139. https:\/\/doi.org\/10.1021\/acsptsci.4c00492","journal-title":"ACS Pharmacol Transl Sci"},{"key":"5269_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1607210","author":"K Chen","year":"2025","unstructured":"Chen K, Sun X, Liu Y et al (2025) Advances in clinical applications of microneedle. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2025.1607210","journal-title":"Front Pharmacol"},{"key":"5269_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jcis.2023.05.080","volume":"647","author":"L Chen","year":"2023","unstructured":"Chen L, Fang D, Zhang J et al (2023) Nanomotors-loaded microneedle patches for the treatment of bacterial biofilm-related infections of wound. J Colloid Interface Sci 647:142\u2013151. https:\/\/doi.org\/10.1016\/j.jcis.2023.05.080","journal-title":"J Colloid Interface Sci"},{"key":"5269_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOPHA.2023.115316","volume":"166","author":"Z Chen","year":"2023","unstructured":"Chen Z, Huang Q, Song Y et al (2023) Cubosomes-assisted transdermal delivery of doxorubicin and indocyanine green for chemo-photothermal combination therapy of melanoma. Biomed Pharmacother 166:115316. https:\/\/doi.org\/10.1016\/J.BIOPHA.2023.115316","journal-title":"Biomed Pharmacother"},{"key":"5269_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-025-01359-0","author":"Z Chen","year":"2025","unstructured":"Chen Z, Liu Y, Lyu M et al (2025a) Classifications of triple \u2011 negative breast cancer: insights and current therapeutic approaches. Cell Biosci. https:\/\/doi.org\/10.1186\/s13578-025-01359-0","journal-title":"Cell Biosci"},{"key":"5269_CR24","doi-asserted-by":"publisher","first-page":"38492","DOI":"10.1039\/d4ra08163c","volume":"14","author":"M Choudhari","year":"2024","unstructured":"Choudhari M, Damle S, Saha RN et al (2024) Formulating abiraterone acetate-HPMCAS-based amorphous solid dispersions: insights into in vitro and biorelevant dissolution assessments and pharmacokinetic evaluations. RSC Adv 14:38492\u201338505. https:\/\/doi.org\/10.1039\/d4ra08163c","journal-title":"RSC Adv"},{"key":"5269_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11041114","volume":"11","author":"S Components","year":"2023","unstructured":"Components S, Techniques P, Applications T (2023) Cubosomes in drug delivery \u2014 a comprehensive review on its structural components, preparation techniques and therapeutic applications. Biomedicines 11:1114","journal-title":"Biomedicines"},{"key":"5269_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S40486-024-00204-2\/FIGURES\/6","volume":"12","author":"R Dave","year":"2024","unstructured":"Dave R, Shinde S, Kalayil N, Budar A (2024) Engineering microscopic delivery systems: a review of dissolving microneedle design, fabrication, and function. Micro Nano Syst Lett 12:1\u201311. https:\/\/doi.org\/10.1186\/S40486-024-00204-2\/FIGURES\/6","journal-title":"Micro Nano Syst Lett"},{"key":"5269_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS15030736\/S1","volume":"15","author":"MR Donthi","year":"2023","unstructured":"Donthi MR, Saha RN, Singhvi G, Dubey SK (2023) Dasatinib-loaded topical nano-emulgel for rheumatoid arthritis: formulation design and optimization by QbD, in vitro, ex vivo, and in vivo evaluation. Pharmaceutics 15:. https:\/\/doi.org\/10.3390\/PHARMACEUTICS15030736\/S1","journal-title":"Pharmaceutics"},{"key":"5269_CR28","doi-asserted-by":"publisher","DOI":"10.15640\/JTHM.V7N2A2","volume":"7","author":"DK Elsayed","year":"2019","unstructured":"Elsayed DK, Daif DR (2019) Use of the Ishikawa diagram to understand the employees\u2019 perceptions towards nepotism in tourism and hospitality industry. JOURNAL OF TOURISM AND HOSPITALITY MANAGEMENT 7:. https:\/\/doi.org\/10.15640\/JTHM.V7N2A2","journal-title":"JOURNAL OF TOURISM AND HOSPITALITY MANAGEMENT"},{"key":"5269_CR29","volume-title":"A comprehensive review on targeted therapies for triple negative breast cancer: an evidence - based treatment guideline","author":"HM Emara","year":"2025","unstructured":"Emara HM, Allam NK, Youness RA (2025) A comprehensive review on targeted therapies for triple negative breast cancer: an evidence - based treatment guideline. Springer, US"},{"key":"5269_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-024-02814-w","volume":"25","author":"MM Faisal","year":"2024","unstructured":"Faisal MM, Gomaa E, Ibrahim AE et al (2024) Verapamil-loaded cubosomes for enhancing intranasal drug delivery: development, characterization, ex vivo permeation, and brain biodistribution studies. AAPS PharmSciTech 25:1\u201315. https:\/\/doi.org\/10.1208\/s12249-024-02814-w","journal-title":"AAPS PharmSciTech"},{"key":"5269_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/J.INOCHE.2024.113504","volume":"170","author":"U Farooq","year":"2024","unstructured":"Farooq U, Hayat S, Nawaz M et al (2024) Cubosomes hydrogel containing silver based organometallic compounds for enhanced wound healing of burns: in vitro and in vivo studies. Inorg Chem Commun 170:113504. https:\/\/doi.org\/10.1016\/J.INOCHE.2024.113504","journal-title":"Inorg Chem Commun"},{"key":"5269_CR32","doi-asserted-by":"publisher","first-page":"6905","DOI":"10.1158\/1078-0432.CCR-11-0288\/12366\/P\/DASATINIB-AS-A-SINGLE-AGENT-IN-TRIPLE-NEGATIVE","volume":"17","author":"RS Finn","year":"2011","unstructured":"Finn RS, Bengala C, Ibrahim N et al (2011) Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study. Clin Cancer Res 17:6905\u20136913. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0288\/12366\/P\/DASATINIB-AS-A-SINGLE-AGENT-IN-TRIPLE-NEGATIVE","journal-title":"Clin Cancer Res"},{"key":"5269_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJPHARM.2024.124195","volume":"658","author":"R Fitaihi","year":"2024","unstructured":"Fitaihi R, Abukhamees S, Chung SH, Craig DQM (2024) Optimization of stereolithography 3D printing of microneedle micro-molds for ocular drug delivery. Int J Pharm 658:124195. https:\/\/doi.org\/10.1016\/J.IJPHARM.2024.124195","journal-title":"Int J Pharm"},{"key":"5269_CR34","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/J.JCIS.2024.08.126","volume":"677","author":"M Fornasier","year":"2025","unstructured":"Fornasier M, Krautforst K, Kulbacka J et al (2025) Cubosomes and hexosomes stabilized by sorbitan monooleate as biocompatible nanoplatforms against skin metastatic human melanoma. J Colloid Interface Sci 677:842\u2013852. https:\/\/doi.org\/10.1016\/J.JCIS.2024.08.126","journal-title":"J Colloid Interface Sci"},{"key":"5269_CR35","doi-asserted-by":"publisher","first-page":"0","DOI":"10.21608\/JABPS.2019.16887.1057","volume":"0","author":"S Gaballa","year":"2019","unstructured":"Gaballa S, El Garhy O, Abdelkader H (2019) Cubosomes: composition, preparation, and drug delivery applications. J Adv Biomed Pharm Sci 0:0\u20130. https:\/\/doi.org\/10.21608\/JABPS.2019.16887.1057","journal-title":"J Adv Biomed Pharm Sci"},{"key":"5269_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adhm.202503503","volume":"03503","author":"P Gao","year":"2025","unstructured":"Gao P, Jiang X, Li J et al (2025) Molecular simulations of polymer-based drug nanocarriers: from physical and structural properties to controlled release. Adv Healthc Mater 03503:1\u201328. https:\/\/doi.org\/10.1002\/adhm.202503503","journal-title":"Adv Healthc Mater"},{"key":"5269_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/J.JDDST.2024.105808","volume":"97","author":"SS Garg","year":"2024","unstructured":"Garg SS, Vyas A, Arivarasan VK, Gupta J (2024) Cubosomes: an emerging nanodrug delivery platform for anti-diabetic medications. J Drug Deliv Sci Technol 97:105808. https:\/\/doi.org\/10.1016\/J.JDDST.2024.105808","journal-title":"J Drug Deliv Sci Technol"},{"key":"5269_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13122888","volume":"13","author":"X Guo","year":"2025","unstructured":"Guo X, Sun H, Yu F et al (2025) Dasatinib inhibits basal B breast cancer through ETS1-mediated extracellular matrix remodeling. Biomedicines 13:2888","journal-title":"Biomedicines"},{"key":"5269_CR39","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1007\/S13346-022-01162-1","volume":"12","author":"T Gupta","year":"2022","unstructured":"Gupta T, Kenjale P, Pokharkar V (2022) QbD-based optimization of raloxifene-loaded cubosomal formulation for transdemal delivery: ex vivo permeability and in vivo pharmacokinetic studies. Drug Deliv Transl Res 12:2979\u20132992. https:\/\/doi.org\/10.1007\/S13346-022-01162-1","journal-title":"Drug Deliv Transl Res"},{"key":"5269_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/J.HELIYON.2023.E15404","author":"VC Gurumukhi","year":"2023","unstructured":"Gurumukhi VC, Sonawane VP, Tapadiya GG et al (2023) Quality-by-design based fabrication of febuxostat-loaded nanoemulsion: statistical optimization, characterizations, permeability, and bioavailability studies. Heliyon. https:\/\/doi.org\/10.1016\/J.HELIYON.2023.E15404","journal-title":"Heliyon"},{"key":"5269_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS13040579","volume":"13","author":"J He","year":"2021","unstructured":"He J, Zhang Z, Zheng X et al (2021) Design and evaluation of dissolving microneedles for enhanced dermal delivery of propranolol hydrochloride. Pharmaceutics 13:579. https:\/\/doi.org\/10.3390\/PHARMACEUTICS13040579","journal-title":"Pharmaceutics"},{"key":"5269_CR42","doi-asserted-by":"publisher","first-page":"7087","DOI":"10.1016\/J.ARABJC.2020.07.014","volume":"13","author":"B Jayagopal","year":"2020","unstructured":"Jayagopal B, Murugesh S (2020) QbD-mediated RP-UPLC method development invoking an FMEA-based risk assessment to estimate nintedanib degradation products and their pathways. Arab J Chem 13:7087\u20137103. https:\/\/doi.org\/10.1016\/J.ARABJC.2020.07.014","journal-title":"Arab J Chem"},{"key":"5269_CR43","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2147\/BCTT.S516542","volume":"17","author":"H Jie","year":"2025","unstructured":"Jie H, Ma W, Huang C (2025) Breast cancer: targets and therapy diagnosis, prognosis, and treatment of triple-negative breast cancer: a review. Breast Cancer Targets Ther 17:265\u2013274","journal-title":"Breast Cancer Targets Ther"},{"key":"5269_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/SU142114497","volume":"14","author":"YT Jou","year":"2022","unstructured":"Jou YT, Silitonga RM, Lin MC et al (2022) Application of six sigma methodology in an automotive manufacturing company: a case study. Sustainability 14:14497. https:\/\/doi.org\/10.3390\/SU142114497","journal-title":"Sustainability"},{"key":"5269_CR45","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/J.JCIS.2024.07.077","volume":"675","author":"GD Kalaycioglu","year":"2024","unstructured":"Kalaycioglu GD, Bor G, Yaghmur A (2024) Simple-by-design approach for production of stabilizer-free cubosomes from phosphatidylglycerol and docosahexaenoic acid monoacylglycerol. J Colloid Interface Sci 675:825\u2013835. https:\/\/doi.org\/10.1016\/J.JCIS.2024.07.077","journal-title":"J Colloid Interface Sci"},{"key":"5269_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJBIOMAC.2024.132074","volume":"269","author":"R Liu","year":"2024","unstructured":"Liu R, Hou W, Li J et al (2024) Co-assembly of cisplatin and Dasatinib in hyaluronan nanogel to combat triple negative breast cancer with reduced side effects. Int J Biol Macromol 269:132074. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2024.132074","journal-title":"Int J Biol Macromol"},{"key":"5269_CR47","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.2147\/DDDT.S499068","volume":"18","author":"D Louis","year":"2024","unstructured":"Louis D, Rizkalla CMZ, Rashad A (2024) Cubosomes as delivery system to repositioning nitrofurantoin in breast cancer management. Drug Des Devel Ther 18:6173\u20136184. https:\/\/doi.org\/10.2147\/DDDT.S499068","journal-title":"Drug Des Devel Ther"},{"key":"5269_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2022.11.016","volume":"182","author":"P Muresan","year":"2023","unstructured":"Muresan P, Mccrorie P, Smith F et al (2023) Development of nanoparticle loaded microneedles for drug delivery to a brain tumour resection site. Eur J Pharm Biopharm 182:1\u20138","journal-title":"Eur J Pharm Biopharm"},{"key":"5269_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-021-01107-0","author":"MI Nasiri","year":"2022","unstructured":"Nasiri MI, Vora LK, Abu J et al (2022) Nanoemulsion \u2011 based dissolving microneedle arrays for enhanced intradermal and transdermal delivery. Drug Deliv Transl Res. https:\/\/doi.org\/10.1007\/s13346-021-01107-0","journal-title":"Drug Deliv Transl Res"},{"key":"5269_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ph14080786","author":"M Nasr","year":"2021","unstructured":"Nasr M, Almawash S, Al Saqr A et al (2021) Bioavailability and antidiabetic activity of gliclazide-loaded cubosomal nanoparticles. Pharmaceuticals. https:\/\/doi.org\/10.3390\/ph14080786","journal-title":"Pharmaceuticals"},{"key":"5269_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJPHARM.2024.123975","volume":"654","author":"R Nisha","year":"2024","unstructured":"Nisha R, Kumar P, Mishra N et al (2024) <article-title update=\"added\">Appraisal of folate functionalized bosutinib cubosomes against hepatic cancer cells: In-vitro, In-silico, and in-vivo pharmacokinetic study. Int J Pharm 654:123975. https:\/\/doi.org\/10.1016\/J.IJPHARM.2024.123975","journal-title":"Int J Pharm"},{"key":"5269_CR52","doi-asserted-by":"publisher","unstructured":"Nishal S, Phaugat P, Gulia M, Jhawat V (2024) Quality by design in quality assurance. Introd to Qual by Des 297\u2013326. https:\/\/doi.org\/10.1007\/978-981-99-8034-5_12","DOI":"10.1007\/978-981-99-8034-5_12"},{"key":"5269_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/NANO12132224","volume":"12","author":"C Oliveira","year":"2022","unstructured":"Oliveira C, Ferreira CJO, Sousa M et al (2022) A versatile nanocarrier\u2014cubosomes, characterization, and applications. Nanomaterials 12:2224. https:\/\/doi.org\/10.3390\/NANO12132224","journal-title":"Nanomaterials"},{"key":"5269_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJPHARM.2020.119942","volume":"591","author":"A Ramalheiro","year":"2020","unstructured":"Ramalheiro A, Paris JL, Silva BFB, Pires LR (2020) Rapidly dissolving microneedles for the delivery of cubosome-like liquid crystalline nanoparticles with sustained release of rapamycin. Int J Pharm 591:. https:\/\/doi.org\/10.1016\/J.IJPHARM.2020.119942","journal-title":"Int J Pharm"},{"issue":"3","key":"5269_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04747-y","volume":"399","author":"H Rana","year":"2025","unstructured":"Rana H, Bhalodia U, Patel A et al (2025a) Ophthalmic-targeted brinzolamide-laden cubosomal solid lipid nano-vesicular system (Cube-SLNV): design, development , and in vitro and ex vivo characterization. Naunyn Schmiedebergs Arch Pharmacol (3):41123637. https:\/\/doi.org\/10.1007\/s00210-025-04747-y","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5269_CR56","volume-title":"Intelligent industry-oriented oro-solid formulation of famotidine: advanced statistical optimization and ex-vivo characterization","author":"H Rana","year":"2024","unstructured":"Rana H, Mistry J, Thakkar V et al (2024a) Intelligent industry-oriented oro-solid formulation of famotidine: advanced statistical optimization and ex-vivo characterization. Elsevier"},{"key":"5269_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s44371-025-00172-5","author":"H Rana","year":"2025","unstructured":"Rana H, Patel G, Thakkar V, Modi C (2025b) Designing of industry friendly pastilles of Rosuvastatin and Piperine integrating green chemistry and advanced statistical approach. Discov Chem. https:\/\/doi.org\/10.1007\/s44371-025-00172-5","journal-title":"Discov Chem"},{"key":"5269_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-024-00702-5","author":"H Rana","year":"2024","unstructured":"Rana H, Pathak P, Patel V et al (2024b) Multichannel 3D\u2011printed bionanoparticles\u2011loaded tablet (M3DPBT): designing, development, and in vitro functionality assessment. Futur J Pharm Sci. https:\/\/doi.org\/10.1186\/s43094-024-00702-5","journal-title":"Futur J Pharm Sci"},{"key":"5269_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/J.MSEC.2020.111548","volume":"119","author":"VK Rapalli","year":"2021","unstructured":"Rapalli VK, Banerjee S, Khan S et al (2021) QbD-driven formulation development and evaluation of topical hydrogel containing ketoconazole loaded cubosomes. Materials Science and Engineering: C 119:111548. https:\/\/doi.org\/10.1016\/J.MSEC.2020.111548","journal-title":"Materials Science and Engineering: C"},{"key":"5269_CR60","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.OPRD.3C00356","volume":"28","author":"PD Rege","year":"2024","unstructured":"Rege PD, Schuster A, Lamerz J et al (2024) QbD approach to process characterization and quantitative criticality assessment of process parameters. Org Process Res Dev 28:. https:\/\/doi.org\/10.1021\/ACS.OPRD.3C00356","journal-title":"Org Process Res Dev"},{"key":"5269_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2025.103402","volume":"338","author":"RM Shah","year":"2025","unstructured":"Shah RM, Jadhav SR, Bryant G et al (2025) On the formation and stability mechanisms of diverse lipid-based nanostructures for drug delivery. Adv Colloid Interface Sci 338:103402. https:\/\/doi.org\/10.1016\/j.cis.2025.103402","journal-title":"Adv Colloid Interface Sci"},{"key":"5269_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/J.HELIYON.2024.E39632\/ASSET\/9DE27AFD-223B-4137-B91A-28A1E4F00B06\/MAIN.ASSETS\/GR11.JPG","volume":"10","author":"R shaikh","year":"2024","unstructured":"shaikh R, Bhattacharya S, Saoji SD (2024) Development, optimization, and characterization of polymeric micelles to improve dasatinib oral bioavailability: Hep G2 cell cytotoxicity and in vivo pharmacokinetics for targeted liver cancer therapy. Heliyon 10:e39632. https:\/\/doi.org\/10.1016\/J.HELIYON.2024.E39632\/ASSET\/9DE27AFD-223B-4137-B91A-28A1E4F00B06\/MAIN.ASSETS\/GR11.JPG","journal-title":"Heliyon"},{"key":"5269_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/J.JDDST.2023.105096","volume":"90","author":"A Singh","year":"2023","unstructured":"Singh A, Rana V (2023) QbD assisted development of inhalable spray-dried erlotinib procubosomal system for the effective management of non-small cell lung cancer. J Drug Deliv Sci Technol 90:105096. https:\/\/doi.org\/10.1016\/J.JDDST.2023.105096","journal-title":"J Drug Deliv Sci Technol"},{"key":"5269_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/J.CHEMPHYSLIP.2022.105193","volume":"244","author":"A Singh","year":"2022","unstructured":"Singh A, Vaish A, Shukla R (2022) Box-behnken design optimized silibinin loaded glycerylmonooleate nanoliquid crystal for brain targeting. Chem Phys Lipids 244:105193. https:\/\/doi.org\/10.1016\/J.CHEMPHYSLIP.2022.105193","journal-title":"Chem Phys Lipids"},{"key":"5269_CR65","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.xphs.2016.03.036","volume":"105","author":"PJ Skrdla","year":"2016","unstructured":"Skrdla PJ, Floyd PD, Dell\u2019orco PC (2016) Practical estimation of amorphous solubility enhancement using thermoanalytical data: determination of the amorphous\/crystalline solubility ratio for pure indomethacin and felodipine. J Pharm Sci 105:2625\u20132630. https:\/\/doi.org\/10.1016\/j.xphs.2016.03.036","journal-title":"J Pharm Sci"},{"key":"5269_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJPHARM.2025.125552","volume":"675","author":"K Soka\u010d","year":"2025","unstructured":"Soka\u010d K, Vrban L, Liovi\u0107 M et al (2025) Controlled release of Dasatinib from cyclodextrin-based inclusion complexes by mechanochemistry: a computational and experimental study. Int J Pharm 675:125552. https:\/\/doi.org\/10.1016\/J.IJPHARM.2025.125552","journal-title":"Int J Pharm"},{"key":"5269_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/J.JDDST.2024.106142","volume":"100","author":"G Tezel","year":"2024","unstructured":"Tezel G, Ulut\u00fcrk S, Re\u00e7ber T et al (2024) Preparation and in vitro characterization of memantine HCl loaded PLGA nanoparticles for Alzheimer\u2019s disease. J Drug Deliv Sci Technol 100:106142. https:\/\/doi.org\/10.1016\/J.JDDST.2024.106142","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"5269_CR68","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4274\/ejbh.galenos.2024.2024-9-9","volume":"21","author":"NBS Thilagam","year":"2025","unstructured":"Thilagam NBS (2025) A comprehensive review on current knowledge and future potential of topical therapies in breast cancer treatment. Eur J Breast Heal 21(1):9\u201315. https:\/\/doi.org\/10.4274\/ejbh.galenos.2024.2024-9-9","journal-title":"Eur J Breast Heal"},{"key":"5269_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0287-3","author":"J Tian","year":"2018","unstructured":"Tian J, Raffa FA, Dai M et al (2018) Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells. Br J Cancer. https:\/\/doi.org\/10.1038\/s41416-018-0287-3","journal-title":"Br J Cancer"},{"key":"5269_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/SSCP.70055","volume":"8","author":"VD Torgal","year":"2025","unstructured":"Torgal VD, Mastiholimath V, Koli R (2025) Development of a stability-indicating RP-HPLC method for pioglitazone in cubosomal and biological matrices: a quality by design-driven, lean six sigma, and green chemistry approach. Sep Sci plus 8:e70055. https:\/\/doi.org\/10.1002\/SSCP.70055","journal-title":"Sep Sci plus"},{"key":"5269_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/J.COLSURFB.2022.112352","volume":"212","author":"DG Villalva","year":"2022","unstructured":"Villalva DG, Fran\u00e7a CG, Loh W (2022) Characterization of cubosomes immobilized in hydrogels of hyaluronic acid and their use for diclofenac controlled delivery. Colloids Surf B Biointerfaces 212:112352. https:\/\/doi.org\/10.1016\/J.COLSURFB.2022.112352","journal-title":"Colloids Surf B Biointerfaces"},{"key":"5269_CR72","doi-asserted-by":"publisher","first-page":"695","DOI":"10.5530\/ijper.57.3.84","volume":"57","author":"N Vishal Gupta","year":"2023","unstructured":"Vishal Gupta N, Jain SC, Jain V, Ravi G (2023) Development, characterization and evaluation of cubosomes loaded smart gel for the treatment of osteomyelitis using 3 2 factorial design. Indian J Pharm Educ Res 57:695\u2013702. https:\/\/doi.org\/10.5530\/ijper.57.3.84","journal-title":"Indian J Pharm Educ Res"},{"key":"5269_CR73","doi-asserted-by":"publisher","first-page":"035","DOI":"10.69613\/22SEEE98","volume":"3","author":"S V","year":"2025","unstructured":"V S, A S, D J, V S (2025) Cubosomes as advanced nanocarriers for drug delivery: review article. J Pharma Insights Res 3:035\u2013042. https:\/\/doi.org\/10.69613\/22SEEE98","journal-title":"J Pharma Insights Res"},{"key":"5269_CR74","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/17425247.2025.2484309","volume":"22","author":"FR Wurm","year":"2025","unstructured":"Wurm FR, Wurm FR (2025) Expert opinion on drug delivery polyphosphoester cubosomes: introducing a novel drug delivery system polyphosphoester cubosomes: introducing a novel drug delivery system. Expert Opin Drug Deliv 22:609\u2013614. https:\/\/doi.org\/10.1080\/17425247.2025.2484309","journal-title":"Expert Opin Drug Deliv"},{"key":"5269_CR75","doi-asserted-by":"publisher","unstructured":"Wakileh W, Watanabe NM, Amatsu Y et al (2025) Investigation of cubosome interactions with liposomal membranes based on time-resolved small-angle X-ray scattering and laurdan fluorescence spectroscopy. B Biomater Membr | 1\u20136. https:\/\/doi.org\/10.1021\/acs.jpcb.4c06060","DOI":"10.1021\/acs.jpcb.4c06060"},{"key":"5269_CR76","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1021\/acs.nanolett.4c06052","volume":"25","author":"W Zhang","year":"2025","unstructured":"Zhang W, Jiang Y, Liu L et al (2025b) Implantable microneedles loaded with nanoparticles surface engineered Escherichia coli for efficient eradication of triple- negative breast cancer stem cells. Nano Lett 25:2041\u20132051. https:\/\/doi.org\/10.1021\/acs.nanolett.4c06052","journal-title":"Nano Lett"},{"key":"5269_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2025.113606","volume":"381","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zhou J, Wang Y et al (2025a) Stimuli-responsive polymer-dasatinib prodrug to reprogram cancer-associated fibroblasts for boosted immunotherapy. J Control Release 381:1\u20137","journal-title":"J Control Release"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05269-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05269-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05269-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:43:28Z","timestamp":1783907008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05269-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":77,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5269"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05269-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}